Adrenoceptor polymorphisms and the risk of cardiac injury and dysfunction after subarachnoid hemorrhage

Document Type

Article

Abstract

BACKGROUND AND PURPOSE: Cardiac abnormalities occur commonly after subarachnoid hemorrhage (SAH) and may be caused by excessive release of catecholamines from the myocardial sympathetic nerves. We hypothesized that adrenoceptor polymorphisms resulting in greater catecholamine sensitivity would be associated with an increased risk of cardiac injury. METHODS: This was a prospective cohort study. The primary outcome variables were the serum level of cardiac troponin I (cTi, abnormal if >1.0 microg/L) and the left ventricular ejection fraction (LVEF, abnormal if <50%). Six adrenoceptor polymorphisms were genotyped: beta1AR Arg389Gly, beta1AR Ser49Gly, beta2AR Gly16Arg, beta2AR Gln27Glu, beta2AR Thr164Ile, and alpha2AR del322-325. The effect of each polymorphism on the risk of developing cardiac abnormalities was quantified using multivariable logistic regression. RESULTS: The study included 182 patients. The CC genotype (Arg/Arg) of beta1AR Arg389Gly (odds ratio [OR] 3.4, P=0.030) and the CC genotype (Gln/Gln) of beta2AR Gln27Glu (OR 3.1, P=0.032) were predictive of cTi release. The presence of the alpha2AR deletion was predictive of reduced LVEF (OR 4.2, P=0.023). The combination of the beta1AR 389 CC and the beta2AR 27 CC genotypes resulted in a marked increase in the odds of cTi release (OR 15.5, P=0.012). The combination of the beta1AR 389 CC and the alpha2AR deletion genotypes resulted in a marked increase in the odds of developing a reduced LVEF (OR 10.3, P=0.033). CONCLUSIONS: Genetic polymorphisms of the adrenoceptors are associated with an increased risk of cardiac abnormalities after SAH. These data support the hypothesis that cardiac dysfunction after SAH is a form of neurocardiogenic injury.

Medical Subject Headings

Catecholamines (blood, metabolism); Cohort Studies; Genotype; Humans; Logistic Models; Myocardial Stunning (etiology, physiopathology); Odds Ratio; Polymorphism, Single Nucleotide; Prospective Studies; Receptors, Adrenergic (genetics, physiology); Risk Assessment; Single-Blind Method; Stroke Volume (physiology); Subarachnoid Hemorrhage (complications, genetics, physiopathology); Troponin I (metabolism); Ventricular Dysfunction, Left (etiology, physiopathology)

Publication Date

5-27-2006

Publication Title

Stroke

E-ISSN

1524-4628

Volume

37

Issue

7

First Page

1680

Last Page

5

PubMed ID

16728691

Digital Object Identifier (DOI)

10.1161/01.STR.0000226461.52423.dd

This document is currently not available here.

Share

COinS